Search 177 catalogue identities by name or alias. Find recorded vendor packages, markets and cited reference notes in one place.
15 entries have a reviewed selection of primary sources. Other entries are marked as awaiting review. A source review covers the stated claims; it does not certify a vendor, a batch, clinical efficacy or suitability for human use.
Categories such as “Healing” and “Weight Loss” are catalogue navigation labels, not evidence of an effect or an approved use. Similar names can identify different compounds; source notes flag reviewed distinctions.
Dermorphin is a catalogue entry whose compound-specific reference review has not yet been completed.
Dihexa is a catalogue entry whose compound-specific reference review has not yet been completed.
Dihexa Capsules is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: delta sleep-inducing peptide
DSIP is a catalogue entry whose compound-specific reference review has not yet been completed.
DSIP Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Eloralintide is a catalogue entry whose compound-specific reference review has not yet been completed.
Enclomiphene Capsules is a catalogue entry whose compound-specific reference review has not yet been completed.
Enclomiphene Solution is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: epitalon · epi
Epithalon is a catalogue entry whose compound-specific reference review has not yet been completed.
Fasoracetam Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Follistatin 344 is a catalogue entry whose compound-specific reference review has not yet been completed.
FOXO4-DRI is a catalogue entry whose compound-specific reference review has not yet been completed.
GHK is glycyl-L-histidyl-L-lysine, a three-amino-acid peptide. Its interaction with copper produces a distinct coordination system, so plain GHK and GHK-Cu need separate identity records.
Aliases: copper peptide
GHK-Cu refers to copper coordination with glycyl-L-histidyl-L-lysine, the tripeptide GHK. The cited chemistry study examines copper binding and the resulting solution species.
GHK-Cu / KPV is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
GHK-Cu / KPV / BPC-157 is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
GHK-Cu Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
GHK-Cu Topical is a catalogue entry whose compound-specific reference review has not yet been completed.
GHRP-2 is a catalogue entry whose compound-specific reference review has not yet been completed.
GHRP-6 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: ghk-cu bpc-157 tb-500
GLOW is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
GLOW (GHK-Cu / TB4 / BPC-157) is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Aliases: gsh
Glutathione is a catalogue entry whose compound-specific reference review has not yet been completed.
Gonadorelin is a catalogue entry whose compound-specific reference review has not yet been completed.
HCG is a catalogue entry whose compound-specific reference review has not yet been completed.
Hexarelin is a catalogue entry whose compound-specific reference review has not yet been completed.
This catalogue label needs an exact sequence specification. FDA describes AOD-9604 as hGH residues 177–191 with an added N-terminal tyrosine; that defined modification should not be silently equated with every “hGH Fragment 176–191” listing.
Humanin is a catalogue entry whose compound-specific reference review has not yet been completed.
IGF-1 DES is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: igf1 lr3 · long r3 igf-1
IGF-1 LR3 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: ipa
Ipamorelin is a five-amino-acid growth hormone secretagogue. Its original characterization used cell and animal experiments; a later human trial investigated a specific postoperative setting.
Aliases: ipa cjc · cjc ipa
Ipamorelin / CJC-1295 is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
ISRIB Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: kisspeptin
Kisspeptin-10 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: ghk-cu bpc-157 tb-500 kpv
KLOW is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
KLOW (GHK-Cu / TB4 / BPC-157 / KPV) is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
KPV is a catalogue entry whose compound-specific reference review has not yet been completed.
L-Carnitine is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: ligandrol
LGD-4033 is a catalogue entry whose compound-specific reference review has not yet been completed.
Lipopeptide (Biopeptide EL) is a catalogue entry whose compound-specific reference review has not yet been completed.